Surgical treatment of recurrent uterine sarcomas

Cover Page

Cite item

Full Text

Abstract

Uterine sarcomas (US) are rare mesodermal tumors comprising 2-7% of all malignant uterine neoplasms. They are the most malignant tumors and differ from a uterine cancer on features of metastasis and tactics of treatment. More than half of patients with uterine sarcoma in different terms have local recurrence and distant metastasis after primary treatment. Treatment algorithms of recurrent uterine sarcomas differ enough. Still there’s no uniform approach to this question. However the surgical method remains the basic method of treatment. Surgeons face great difficulties because relapse of uterine sarcomas quite often extends on other pelvic organs. Despite it, surgery gives chance to achieve long remission.

About the authors

I. V. Matrosova

Russian Academy for Postgraduate Medical Education

Author for correspondence.
Email: mivnda@mail.ru
Russian Federation

N. I. Lazareva

N.N. Blokhin Russian Cancer Research Center, RussianAcademy of Medical Sciences

Russian Federation

I. A. Fainshtein

N.N. Blokhin Russian Cancer Research Center, RussianAcademy of Medical Sciences

Russian Federation

I. V. Poddubnaya

Russian Academy for Postgraduate Medical Education

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2010 Matrosova I.V., Lazareva N.I., Fainshtein I.A., Poddubnaya I.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-66671 от  09.11.2009.